Article
A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.
Digestive diseases and sciences - 1 Sept 2010
Méndez-Navarro Jorge, Chirino Ruby A, Corey Kathleen E, Gorospe Emmanuel C, Zheng Hui, Morán Segundo, Juarez Jesus A, Chung Raymond T, Dehesa-Violante Margarita
Abstract excerpt
BACKGROUND: With only a third of Latinos achieving sustained virologic response (SVR), there is a need for enhanced HCV treatment. Amantadine has been proposed to improve response rates in addition to standard therapy with peginterferon alpha and ribavirin. Our objective is to evaluate whether triple therapy with amantadine improves SVR rates in this special population. METHOD: Treatment-naïve Latino subjects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.